Every time the AI Express, some investors ask questions on the investor interactive platform: Has the company’s new crown detection reagents been approved by the US government for listing?
ST Toyo(002086.SZ) stated on the investor interactive platform on January 19 that the new coronavirus (2019-nCoV) IgG/IgM antibody detection kit (colloidal gold method) and the new coronavirus (SARS) of Aveco Biotechnology Co., Ltd. -CoV-2) antigen detection kit (colloidal gold method) has obtained EU access qualification and is currently produced according to orders. The actual sales situation is affected by various factors and there are uncertainties. The relevant financial data for 2021 is under statistics. For specific sales, please pay attention to the company’s regular reports. Investors are advised to make prudent decisions and pay attention to investment risks. The company’s designated information disclosure media is “securitiesTimes, “Shanghaisecuritiesnewspaper, “ChinasecuritiesNewspaper, Securities Daily and Juchao Information Network (www.cninfo.com.cn), the information released by the company is based on the information published in the above mediaannouncementprevail.
(Article source: Daily Economic News)
Article source: Daily Economic News
Responsible editor: 43
Original title: ST Dongyang: Two novel coronavirus detection kits of Aveco Biotechnology Co., Ltd. have obtained EU access qualifications
Solemnly declare: Oriental Fortune.com releases this information for the purpose of disseminating more information and has nothing to do with the position of this site.
report
Scan the QR code to follow
Oriental Fortune official website WeChat
.